Global Cas Nuclease Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01244597

Publication Date:

January 4, 2024

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Cas Nuclease market size was valued at US$ 143.4 million in 2023. With growing demand in downstream market, the Cas Nuclease is forecast to a readjusted size of US$ 845.7 million by 2030 with a CAGR of 28.9% during review period.
The research report highlights the growth potential of the global Cas Nuclease market. Cas Nuclease are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cas Nuclease. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cas Nuclease market.
The main manufacturers of Cas nuclease include Thermo Fisher Scientific, GenScript and Integrated DNA Technologies, Inc., etc. The top three manufacturers account for about 45% of the share. North America is the largest market with about 44% share, followed by Europe and China with about 35% and 8% of the market. Cas9 is the largest segment with an 85% share. Gene editing cell line construction was the largest application with about 40% share.
Key Features:
The report on Cas Nuclease market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cas Nuclease market. It may include historical data, market segmentation by Type (e.g., Cas9, Cas12), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cas Nuclease market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cas Nuclease market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cas Nuclease industry. This include advancements in Cas Nuclease technology, Cas Nuclease new entrants, Cas Nuclease new investment, and other innovations that are shaping the future of Cas Nuclease.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cas Nuclease market. It includes factors influencing customer ' purchasing decisions, preferences for Cas Nuclease product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cas Nuclease market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cas Nuclease market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cas Nuclease market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cas Nuclease industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cas Nuclease market.
Market Segmentation:
Cas Nuclease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Cas9
Cas12
Cas13
Others
Segmentation by application
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cas Nuclease Market Size 2019-2030
2.1.2 Cas Nuclease Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cas Nuclease Segment by Type
2.2.1 Cas9
2.2.2 Cas12
2.2.3 Cas13
2.2.4 Others
2.3 Cas Nuclease Market Size by Type
2.3.1 Cas Nuclease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cas Nuclease Market Size Market Share by Type (2019-2024)
2.4 Cas Nuclease Segment by Application
2.4.1 Gene Editing Cell Line Construction
2.4.2 Animal Models
2.4.3 Bioagriculture
2.4.4 Gene Therapy
2.4.5 Other
2.5 Cas Nuclease Market Size by Application
2.5.1 Cas Nuclease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cas Nuclease Market Size Market Share by Application (2019-2024)
3 Cas Nuclease Market Size by Player
3.1 Cas Nuclease Market Size Market Share by Players
3.1.1 Global Cas Nuclease Revenue by Players (2019-2024)
3.1.2 Global Cas Nuclease Revenue Market Share by Players (2019-2024)
3.2 Global Cas Nuclease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cas Nuclease by Regions
4.1 Cas Nuclease Market Size by Regions (2019-2024)
4.2 Americas Cas Nuclease Market Size Growth (2019-2024)
4.3 APAC Cas Nuclease Market Size Growth (2019-2024)
4.4 Europe Cas Nuclease Market Size Growth (2019-2024)
4.5 Middle East & Africa Cas Nuclease Market Size Growth (2019-2024)
5 Americas
5.1 Americas Cas Nuclease Market Size by Country (2019-2024)
5.2 Americas Cas Nuclease Market Size by Type (2019-2024)
5.3 Americas Cas Nuclease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cas Nuclease Market Size by Region (2019-2024)
6.2 APAC Cas Nuclease Market Size by Type (2019-2024)
6.3 APAC Cas Nuclease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cas Nuclease by Country (2019-2024)
7.2 Europe Cas Nuclease Market Size by Type (2019-2024)
7.3 Europe Cas Nuclease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cas Nuclease by Region (2019-2024)
8.2 Middle East & Africa Cas Nuclease Market Size by Type (2019-2024)
8.3 Middle East & Africa Cas Nuclease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cas Nuclease Market Forecast
10.1 Global Cas Nuclease Forecast by Regions (2025-2030)
10.1.1 Global Cas Nuclease Forecast by Regions (2025-2030)
10.1.2 Americas Cas Nuclease Forecast
10.1.3 APAC Cas Nuclease Forecast
10.1.4 Europe Cas Nuclease Forecast
10.1.5 Middle East & Africa Cas Nuclease Forecast
10.2 Americas Cas Nuclease Forecast by Country (2025-2030)
10.2.1 United States Cas Nuclease Market Forecast
10.2.2 Canada Cas Nuclease Market Forecast
10.2.3 Mexico Cas Nuclease Market Forecast
10.2.4 Brazil Cas Nuclease Market Forecast
10.3 APAC Cas Nuclease Forecast by Region (2025-2030)
10.3.1 China Cas Nuclease Market Forecast
10.3.2 Japan Cas Nuclease Market Forecast
10.3.3 Korea Cas Nuclease Market Forecast
10.3.4 Southeast Asia Cas Nuclease Market Forecast
10.3.5 India Cas Nuclease Market Forecast
10.3.6 Australia Cas Nuclease Market Forecast
10.4 Europe Cas Nuclease Forecast by Country (2025-2030)
10.4.1 Germany Cas Nuclease Market Forecast
10.4.2 France Cas Nuclease Market Forecast
10.4.3 UK Cas Nuclease Market Forecast
10.4.4 Italy Cas Nuclease Market Forecast
10.4.5 Russia Cas Nuclease Market Forecast
10.5 Middle East & Africa Cas Nuclease Forecast by Region (2025-2030)
10.5.1 Egypt Cas Nuclease Market Forecast
10.5.2 South Africa Cas Nuclease Market Forecast
10.5.3 Israel Cas Nuclease Market Forecast
10.5.4 Turkey Cas Nuclease Market Forecast
10.5.5 GCC Countries Cas Nuclease Market Forecast
10.6 Global Cas Nuclease Forecast by Type (2025-2030)
10.7 Global Cas Nuclease Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Cas Nuclease Product Offered
11.1.3 Thermo Fisher Scientific Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 GenScript
11.2.1 GenScript Company Information
11.2.2 GenScript Cas Nuclease Product Offered
11.2.3 GenScript Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GenScript Main Business Overview
11.2.5 GenScript Latest Developments
11.3 Integrated DNA Technologies, Inc.
11.3.1 Integrated DNA Technologies, Inc. Company Information
11.3.2 Integrated DNA Technologies, Inc. Cas Nuclease Product Offered
11.3.3 Integrated DNA Technologies, Inc. Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Integrated DNA Technologies, Inc. Main Business Overview
11.3.5 Integrated DNA Technologies, Inc. Latest Developments
11.4 Aldevron
11.4.1 Aldevron Company Information
11.4.2 Aldevron Cas Nuclease Product Offered
11.4.3 Aldevron Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Aldevron Main Business Overview
11.4.5 Aldevron Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Cas Nuclease Product Offered
11.5.3 Merck Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Horizon Discovery
11.6.1 Horizon Discovery Company Information
11.6.2 Horizon Discovery Cas Nuclease Product Offered
11.6.3 Horizon Discovery Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Horizon Discovery Main Business Overview
11.6.5 Horizon Discovery Latest Developments
11.7 Agilent
11.7.1 Agilent Company Information
11.7.2 Agilent Cas Nuclease Product Offered
11.7.3 Agilent Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Agilent Main Business Overview
11.7.5 Agilent Latest Developments
11.8 OriGene Technologies, Inc
11.8.1 OriGene Technologies, Inc Company Information
11.8.2 OriGene Technologies, Inc Cas Nuclease Product Offered
11.8.3 OriGene Technologies, Inc Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 OriGene Technologies, Inc Main Business Overview
11.8.5 OriGene Technologies, Inc Latest Developments
11.9 New England Biolabs
11.9.1 New England Biolabs Company Information
11.9.2 New England Biolabs Cas Nuclease Product Offered
11.9.3 New England Biolabs Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 New England Biolabs Main Business Overview
11.9.5 New England Biolabs Latest Developments
11.10 NIPPON GENE CO., LTD.
11.10.1 NIPPON GENE CO., LTD. Company Information
11.10.2 NIPPON GENE CO., LTD. Cas Nuclease Product Offered
11.10.3 NIPPON GENE CO., LTD. Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 NIPPON GENE CO., LTD. Main Business Overview
11.10.5 NIPPON GENE CO., LTD. Latest Developments
11.11 Novoprotein
11.11.1 Novoprotein Company Information
11.11.2 Novoprotein Cas Nuclease Product Offered
11.11.3 Novoprotein Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Novoprotein Main Business Overview
11.11.5 Novoprotein Latest Developments
11.12 Applied Biological Materials Inc. (abm)
11.12.1 Applied Biological Materials Inc. (abm) Company Information
11.12.2 Applied Biological Materials Inc. (abm) Cas Nuclease Product Offered
11.12.3 Applied Biological Materials Inc. (abm) Cas Nuclease Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Applied Biological Materials Inc. (abm) Main Business Overview
11.12.5 Applied Biological Materials Inc. (abm) Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂